STOCK TITAN

Spectral AI to Participate at the Sidoti Micro-Cap Virtual Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences AI
Rhea-AI Summary

Spectral AI, Inc. (Nasdaq: MDAI) will be participating in the Sidoti Micro-Cap Virtual Investor Conference on May 8-9, 2024. The company focuses on AI for medical diagnostics in wound care. Interested parties can access the live presentation and webcast on the company's website. Registration for the event is free.

Positive
  • None.
Negative
  • None.

DALLAS, May 02, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that management is scheduled to present and host one-on-one meetings with investors at the Sidoti Micro-Cap Virtual Investor Conference, taking place on May 8-9, 2024.

The Company’s presentation will begin at 12:15 pm ET on May 9, 2024 and can be accessed live here. Interested parties may also access the live and archived webcast of the presentation by visiting the Investors section of Spectral AI’s website at https://investors.spectral-ai.com/news-events/events.

To register for the presentation or one-on-ones, visit www.sidoti.com/events. Registration is free and participants do not need to be a client of Sidoti & Company LLC.

About Spectral AI
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView™ System. DeepView is a predictive device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of exceeding the current standard of care in the future, DeepView is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about DeepView, visit www.spectral-ai.com.

Forward-Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.

These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.

Investors should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.

Investors:
 
  
The Equity Group 
Devin SullivanConor Rodriguez
Managing DirectorAnalyst
dsullivan@equityny.comcrodriguez@equityny.com
  
 Media:
 
  
Russo Partners 
David Schull 
Russo Partners 
(858) 717-2310 
david.schull@russopartnersllc.com 

FAQ

When is Spectral AI participating in the Sidoti Micro-Cap Virtual Investor Conference?

Spectral AI will be participating in the Sidoti Micro-Cap Virtual Investor Conference on May 8-9, 2024.

What is the focus of Spectral AI as a company?

Spectral AI focuses on artificial intelligence for medical diagnostics in wound care.

Where can interested parties access the live presentation and webcast?

Interested parties can access the live presentation and webcast on Spectral AI's website at https://investors.spectral-ai.com/news-events/events.

Is registration required to attend the presentation or one-on-one meetings?

Registration for the presentation or one-on-one meetings can be done for free at www.sidoti.com/events.

Spectral AI, Inc.

NASDAQ:MDAI

MDAI Rankings

MDAI Latest News

MDAI Stock Data

20.95M
17.61M
46.74%
21.01%
3.38%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
DALLAS